Tuesday, November 03, 2020 8:58:58 AM
Marlborough continues to add to reputation as biotech, life sciences hub
Excerpts:
Revance Therapeutics is seeking a tax increment financing deal to open a facility on Campus Drive. Sartorius announced plans last week to expand its North American manufacturing operations with a new facility on Locke Drive in Marlborough.
MARLBOROUGH – The city is continuing to add to its reputation as a hub for life science and biotech companies.
Newark, California-based Revance Therapeutics Inc. – a biotech company – is seeking a tax increment financing deal with the city to open a facility for commercial aseptic fill operations and research and development on Campus Drive.
Marlborough, in recent years, has attracted several life science and biotech companies, bringing hundreds of new jobs to the region.
“Due to its strong and growing commitment to the life sciences industry, Marlborough is rated a Platinum BioReadyTM Community by the Massachusetts Biotechnology Council (MassBio),” Mayor Arthur Vigeant wrote in a letter to the City Council. “This puts the city among the most favorable biotech destinations in the state, just 7% of Massachusetts communities have achieved ‘Platinum status.’ This investment equates to new job opportunities in our community and additional tax revenue ensuring the tax burden does not fall solely on our residents.”
Revance Therapeutics
Revance plans to lease a 79,000 square-foot single-tenant building on Campus Drive and construct parking facilities, the mayor said in his letter.
“Revance Therapeutics will create and maintain 76 permanent, full-time jobs available to qualified residents of Marlborough at the projected area,” Vigeant wrote. “Additionally, improvements to the Project Area are estimated in an initial capital investment of approximately $115 million in combined soft, real property and personal property costs.”
The company – which has about 430 employees – has been in talks with city leaders about opening a facility for the past few months.
Brian Blagg, vice president of engineering, facilities and supply chain, wrote a letter to city officials saying the company’s primary objectives were to find a facility that meets all operational requirements, a location where the company can hire and retain exceptional talent, lower operating costs, operate in a stable and business-friendly environment with an improved tax structure and provide flexibility for future growth.
“Revance Therapeutics is therefore requesting that you accept this letter as the formal letter of intent required under the Economic Development Incentive Program, (EDIP),” Blagg wrote in his letter.
https://marlborough.wickedlocal.com/news/20201102/marlborough-continues-to-add-to-reputation-as-biotech-life-sciences-hub
Recent RVNC News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 11:32:37 AM
- Kuehn Law Encourages RVNC, RFL, BTTR, and ARC Investors to Contact Law Firm • PR Newswire (US) • 09/27/2024 01:17:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 11:15:36 AM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/16/2024 09:01:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:06:45 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 09/05/2024 09:27:28 PM
- Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 09/05/2024 08:45:25 PM
- Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 08/13/2024 01:29:06 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 08/12/2024 09:18:26 PM
- Rowley Law PLLC is Investigating Proposed Acquisition of Revance Therapeutics, Inc. • PR Newswire (US) • 08/12/2024 07:18:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 01:20:58 PM
- Crown Laboratories and Revance Announce Entry Into Merger Agreement • PR Newswire (US) • 08/12/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 01:00:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:34:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:07:57 PM
- Revance Reports Second Quarter 2024 Financial Results, Provides Corporate Update • Business Wire • 08/08/2024 08:05:00 PM
- Revance to Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024 • Business Wire • 08/01/2024 08:05:00 PM
- Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/14/2024 08:05:00 PM
- Revance to Participate in Upcoming Investor Conferences • Business Wire • 05/28/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:33:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:08:10 PM
- Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update • Business Wire • 05/09/2024 08:06:00 PM
- Revance Expands into the U.S. Therapeutics Market with the Launch of DAXXIFY® for the Treatment of Cervical Dystonia • Business Wire • 05/09/2024 08:05:00 PM
- Revance to Release First Quarter 2024 Financial Results on Thursday, May 9, 2024 • Business Wire • 05/02/2024 08:05:00 PM
- Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting • Business Wire • 04/12/2024 12:00:00 PM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM